# Uncertainty Analysis

## Purpose

Machine learning predictions contain uncertainty arising from biological, experimental, statistical, and computational sources.

This document summarizes the major uncertainty sources present in the Whole-Cell Biosensor Fingerprint Machine Learning Platform and describes current mitigation strategies.

---

## Biological Uncertainty

### Source

Whole-cell biosensors are living systems and may exhibit:

- Growth variability
- Metabolic variability
- Cellular adaptation
- Strain-specific responses

### Potential Impact

These factors may alter luminescence responses even when exposed to identical contaminants.

### Current Mitigation

- Multiple biosensor strains
- Cross-strain validation
- Feature normalization
- Panel optimization studies

---

## Experimental Uncertainty

### Source

Experimental measurements may be influenced by:

- Instrument variability
- Timing variation
- Pipetting error
- Environmental fluctuations

### Potential Impact

Differences between experiments may reduce model generalization.

### Current Mitigation

- Standardized preprocessing
- Experiment normalization
- Leave-One-Experiment-Out validation

---

## Feature Extraction Uncertainty

### Source

Feature extraction converts complex time-series data into summary descriptors.

Examples include:

- AUC
- Maximum Signal
- Time-to-Peak
- Fold Change
- Derivative Features

### Potential Impact

Some biological information may be lost during feature compression.

### Current Mitigation

- Multiple complementary features
- Advanced temporal feature engineering
- Feature importance analysis

---

## Model Uncertainty

### Source

Model outputs may vary due to:

- Training data composition
- Random initialization
- Experimental noise
- Feature selection

### Potential Impact

Performance estimates may vary across independent datasets.

### Current Mitigation

- Holdout validation
- LOEO validation
- Leave-One-Strain-Out validation
- Panel ablation studies

---

## Generalization Uncertainty

### Source

Future datasets may differ from the training data.

Potential differences include:

- New contaminants
- New biosensor strains
- Different laboratories
- Environmental deployment conditions

### Potential Impact

Performance may decline when deployed outside the current experimental scope.

### Current Mitigation

- Cross-experiment validation
- Cross-strain validation
- Limitation reporting

---

## Current Robustness Evidence

The following analyses provide evidence of robustness:

- Leave-One-Experiment-Out validation
- Leave-One-Strain-Out validation
- Feature importance analysis
- Panel optimization
- Per-chemical performance evaluation

---

## Recommended Future Improvements

Future versions should incorporate:

### Statistical Uncertainty

- Bootstrap confidence intervals
- Confidence bounds on performance metrics

### Predictive Uncertainty

- Probability calibration
- Prediction confidence estimates

### Model Uncertainty

- Ensemble methods
- Bayesian approaches

### Deployment Uncertainty

- External laboratory validation
- Field deployment validation

---

## Conclusion

The current framework includes multiple validation strategies that reduce dependence on individual experiments and strains. Additional uncertainty quantification would further strengthen publication-level readiness and deployment confidence.